Anti-Bacillus anthracis protective antigen antibody (ab13808)

Overview

  • Product nameAnti-Bacillus anthracis protective antigen antibody
    See all Bacillus anthracis protective antigen primary antibodies
  • Description
    Rabbit polyclonal to Bacillus anthracis protective antigen
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Anthrax PA produced by Bacillus anthracis
  • Immunogen

    Synthetic peptide corresponding to amino acids 238-254 of Anthrax PA

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: 0.05% Sodium Azide
    Constituents: 0.2% Gelatin, PBS
  • PurityWhole antiserum
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab13808 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000. Detects a band of approximately 83 kDa.

Target

  • RelevanceAnthrax toxins are composed of three distinct proteins, a protective antigen (PA), a lethal factor (LF) and an edema factor (EF). None of these proteins are toxic by themselves and several studies indicate that the anthrax toxin has the familiar A-B enzymatic binding structure, with PA acting as the binding domain and EF and/or LF acting as the active fragments.
  • Cellular localizationSecreted
  • Alternative names
    • PA antibody
    • PA83 antibody
    • pag antibody
    • PagA antibody
    • Protective antigen antibody
    see all

Anti-Bacillus anthracis protective antigen antibody images

  • Western blot analysis of Anthrax PA in recombinant protein using ab13808 (lane B) at 1:1000 dilution. Lane A shows the pre-bleed.

References for Anti-Bacillus anthracis protective antigen antibody (ab13808)

This product has been referenced in:
  • Wilson MK  et al. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice. Infect Immun 79:3012-9 (2011). WB . Read more (PubMed: 21576337) »
  • Martchenko M  et al. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci U S A 107:15583-8 (2010). WB . Read more (PubMed: 20713715) »

See all 2 Publications for this product

Product Wall

Thank you for your reply.


Since this is not purified, we can only provide a rough estimate of the IgG concentration, 1-5 mg/ml.


I hope this information is helpful. Please do not hesitate to contact me if you have any additio...

Read More

Thank you for contacting Abcam regarding ab13808.


Regarding the production of this antibody, the immunogen is a synthetic peptide comprised of amino acids 240-254 of the Anthrax PA protein. No further details are available at this time. Read More

Thank you for contacting us. PA is cleaved from the 83 kDa form to the 63 kDa form at amino acids 164-167. Thus the antibody (made against amino acids 250-250) should recognize both the 83 kDa and 63 kDa PA forms, but not the 20 kDa cleavage fragment. ...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"